Article: Two Landmark Studies Report Encouraging New Data on Children's Growth and Asthma Control With Long-term Use of Inhaled Corticosteroid - New England Journal of Medicine.

WAYNE, Pa., Oct. 11 /PRNewswire/ --

Millions of children suffer from asthma, a serious, inflammatory lung disease that can be life-threatening when poorly controlled. Inhaled corticosteroids are recommended by the National Institutes of Health (NIH) as the most effective anti-inflammatory treatments to help control persistent asthma -- although there has been limited research on their long-term use. Now two landmark studies reported today in the New England Journal of Medicine show encouraging new data on asthma management and children's growth with long-term use of Pulmicort(R) (budesonide), an inhaled corticosteroid, made by AstraZeneca.

Given the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!